PIK3C2A and Hypertension: The most frequent adverse events, occurring in more than 10 % of patients, were hypertension (20 %) and CPK elevation (12 %) in the clevudine 30 mg group and upper respiratory tract infection (17 %) and CPK elevation (13 %) in the clevudine 20 mg group.